Clinical observation of acute infective endophthalmitis after cataract extraction combined with intraocular lens implantation

doi:10.3877/cma.j.issn.2095-2007.2018.01.002

Abstract

Abstract:

Objective

To observe and discuss the treatment strategy of acute infective endophthalmitis after cataract extraction combined with intraocular lens (IOL) implantation.

Methods

The clinical data of 9 patients with acute infectious endophthalmitis after cataract extraction and IOL implantation were collected from 2011~2017 years′ ophthalmology hospital in Guangzhou. Among them, there was one case of endophthalmitis after cataract surgery in Guangzhou Eye Hospital, 8 cases of endophthalmitis referral patients after cataract surgery in primary hospitals.Check the results of the patient′s visual acuity, intraocular pressure, anterior segment, ocular ultrasound scan and so on. The patients were treated with parsplana vitrectomy (PPV) and the patients were infected with IOL and silicone oil filling. During the operation, the anterior chamber fluid and the glass fluid were given to the bacteria and fungi.

Results

Among the 9 patients, there were 1 patients with diabetes, 2 patients with hypertension, and the rest had no long-term systemic disease. All patients in this acute infectious endophthalmitis after cataract surgery in time was 1~9 days, showed a sharp decline in visual acuity, eye pain, conjunctival hyperemia and edema, corneal edema of different degrees, aqueous humor with/without hypopyon and anterior chamber exudation membrane etc.. The results of ocular ultrasound examination revealed the vitreous opacity of the patient and the fundus of the eyes were not seen. In 9 cases, 8 cases were treated by full vitrectomy and one case of full vitrectomy was not performed due to corneal opacity. 6 cases were practiced intravitreal injection before vitrectomy. In the first 3 cases were taken out with IOL and silicone tamponade, but the other 6 cases were not necessary of IOL removal and silicone tamponade. Postoperative visual acuity was improved in 7 of 9 cases. Visual acuity 0.01~0.09 were in 2 cases, 0.1~0.3 were in 3 cases and 0.3~0.5 were in 2 cases. one case with no improvement of vision and 1 case was practiced evisceration due to infection spreading.

Conclusion

PPV is an effective treatment for acute infectious endophthalmitis after cataract surgery. It plays an important role on controlled the infection and retained the visual function of patients, especially in well corneal condition cases.

Key words: Acute infective endophthalmitis, Cataract removal, Parsplana vitrectomy

Qianyin Chen, Jinglin Zhang, Zhende Lin, Zheming Wu, Huimin Lin. Clinical observation of acute infective endophthalmitis after cataract extraction combined with intraocular lens implantation[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2018, 08(01): 9-14.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhykyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2007.2018.01.002

https://zhykyxzz.cma-cmc.com.cn/EN/Y2018/V08/I01/9

Figures/Tables 4

References 44

[1]	Yao K, Zhu Y, Zhu Z, et al. The incidence of postoperative endophthalmitis after cataract surgery in China: a multicenter investigation of 2006－2011[J]. Bri J Ophthalmol, 2013, 97(10):1312-1317.
[2]	Hegazy HM, Kivilcim M, Peyman GA, et al. Evaluation of toxicity of intravitreal ceftazidime, vancomycin, and ganciclovir in a silicone oil－filled eye[J]. Retina, 1999, 19(6):553-557.
[3]	Sheng Y, Sun W, Gu Y, et al. Endophthalmitis after cataract surgery in China, 1995－2009[J]. J Cataract Refract Surg, 2011, 37(9):1715-1722.
[4]	Durand ML, Miller JW, Young LH. Endophthalmitis[J]. Clinical Microbiology & Infection, 2013, 19(3):227-234.
[5]	Cao H, Zhang L, Li L, et al. Risk Factors for Acute Endophthalmitis following Cataract Surgery: A Systematic Review and Meta－Analysis[J]. PloS One, 2013, 8(8):e71731.
[6]	Schmier J, Hulme－Lowe C, Covert D, et al. An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010－2014[J]. Clin Ophthalmol, 2016, 10(2016):2121-2127.
[7]	Friling E, Lundström M, Stenevi U, et al. Six－year incidence of endophthalmitis after cataract surgery: Swedish national study[J]. J Cataract Refract Surg, 2013, 39(1):15-21.
[8]	Chiquet C, Boisset S, Pechinot A, et al. Massilia timonae as cause of chronic endophthalmitis following cataract surgery[J]. J Cataract Refract Surg, 2015, 41(8):1778-1780.
[9]	Matsuura K, Miyoshi T, Suto C, et al. Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan[J]. J Cataract Refract Surg, 2013, 39(11):1702-1706.
[10]	Lundström M, Wejde G, Stenevi U, et al. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location[J]. Ophthalmology, 2007, 114(5):866-870.
[11]	Hatch W, Cernat GD, Devenyi R, et al. Risk factors for acute endophthalmitis after cataract surgery: a population－based study[J]. Ophthalmology, 2009, 116(3):425-430.
[12]	Freeman EE, Roygagnon MH, Fortin E, et al. Rate of endophthalmitis after cataract surgery in Quebec, Canada, 1996－2005[J]. Arch Ophthalmol, 2010, 128(2):230-234.
[13]	Braga－Mele R, Chang DF, Henderson BA, et al. Intracameral antibiotics: Safety, efficacy, and preparation[J]. J Cataract Refract Surg, 2014, 40(12):2134-2142.
[14]	中华医学会眼科学分会白内障及人工晶状体学组. 我国白内障摘除手术后感染性眼内炎防治专家共识(2017年)[J]. 中华眼科杂志，2017, 53(11):810-813.
[15]	Jabbarvand M, Hashemian H, Khodaparast M, et al. Endophthalmitis Occurring after Cataract Surgery: Outcomes of More Than 480 000 Cataract Surgeries, Epidemiologic Features, and Risk Factors[J]. Ophthalmology, 2016, 123(2):295-301.
[16]	West ES, Behrens A, Mcdonnell PJ, et al. The incidence of endophthalmitis after cataract surgery among the U．S. Medicare population increased between 1994 and 2001[J]. Ophthalmology, 2005, 112(8):1388-1394.
[17]	Li J, Morlet N, Ng JQ, et al. Significant Nonsurgical Risk Factors for Endophthalmitis after Cataract Surgery: EPSWA Fourth Report[J]. Invest Ophthalmol Vis Sci, 2004, 45(5):1321-1328.
[18]	Lundström M, Friling E, Montan P. Risk factors for endophthalmitis after cataract surgery: Predictors for causative organisms and visual outcomes[J]. J Cataract Refract Surg, 2015, 41(11):2410-2416.
[19]	Norregaard JC, Thoning H, Bernthpetersen P, et al. Risk of endophthalmitis after cataract extraction: results from the International Cataract Surgery Outcomes study[J]. Am J Ophthalmol, 1997, 123(8):689-693.
[20]	Barry P, Seal D, Gettinby G, et al. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors[J]. J Cataract Refract Surg, 2007, 33(6):978-988.
[21]	Keay L, Gower EW, Cassard SD, et al. Postcataract Surgery Endophthalmitis in the United States: Analysis of the Complete 2003 to 2004 Medicare Database of Cataract Surgeries[J]. Ophthalmology, 2012, 119(5):914-922.
[22]	Ahmed Y, Scott IU, Pathengay A, et al. Povidone－Iodine for Endophthalmitis Prophylaxis[J]. Am J Ophthalmol, 2014, 157(3):503-504.
[23]	Scott WJ. Povidone－iodine antisepsis for cataract surgery and ophthalmic procedures[J]. Am J Ophthalmol. 2011, 151(5):914-915.
[24]	Tan CSH, Lim LW, Kai XC. Incidence of postoperative endophthalmitis with the use of povidone－iodine[J]. J Cataract Refract Surg, 2015, 41(4):903-904.
[25]	Shorstein NH, Winthrop KL, Herrinton LJ. Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department[J]. J Cataract Refract Surg, 2013, 39(1):8-14.
[26]	Rodríguezcaravaca G, Garcíasáenz MC, Villardelcampo MC, et al. Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery[J]. J Cataract Refract Surg, 2013, 39(9):1399-1403.
[27]	Herrinton LJ, Shorstein NH, Paschal JF, et al. Comparative Effectiveness of Antibiotic Prophylaxis in Cataract Surgery[J]. Ophthalmology, 2016, 123(2):287-294.
[28]	Fintelmann RE, Naseri A. Prophylaxis of postoperative endophthalmitis following cataract surgery: current status and future directions[J]. Drugs, 2010, 70(11):1395-1409.
[29]	Wejde G, Montan P, Lundström M, et al. Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999－2001[J]. Acta Ophthalmologica, 2005, 83(1):7-10.
[30]	García－Sáenz MC, Arias－Puente A, Rodríguez－Caravaca G, et al. Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten－year comparative study[J]. J Cataract Refract Surg, 2010, 36(2):203-207.
[31]	Yuwaiman P, Morgan SJ, Hildreth AJ, et al. Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery[J]. J Cataract Refract Surg, 2008, 34(3):447-451.
[32]	Schwartz SG, FH Jr, Grzybowski A, et al. Intracameral Antibiotics and Cataract Surgery: Endophthalmitis Rates, Costs, and Stewardship[J]. Ophthalmology, 2016, 123(7):1411-1413.
[33]	Comer GM, Miller JB, Schneider EW, et al. Intravitreal daptomycin: a safety and efficacy study[J]. Retina, 2011, 31(6):1199-1206.
[34]	Doft BH, Kelsey SF, Wisniewski S, et al. Treatment of endophthalmitis after cataract extraction[J]. Retina, 1994, 14(4):297-304.
[35]	Gower EW, Keay LJ, Stare DE, et al. Characteristics of Endophthalmitis after Cataract Surgery in the United States Medicare Population[J]. Ophthalmology, 2015, 122(8):1625-1632.
[36]	Almanjoumi AM, Combey A, Romanet JP, et al. 23－gauge transconjunctival sutureless vitrectomy in treatment of post－operative endophthalmitis[J]. Graefe′s Archive for Clinical and Experimental Ophthalmology, 2012, 250(9):1367-1371.
[37]	Altan T, Kapran Z, Eser I, et al. Comparative outcomes of pars plana vitrectomy in acute postoperative endophthalmitis with 25－gauge and 20－gauge techniques[J]. Japanese Journal of Ophthalmology, 2009, 53(5):506-511.
[38]	Rejdak R, Choragiewicz T, Kalinowska A, et al. Vancomycin in infusion during vitrectomy in surgical treatment of acute postoperative and posttraumatic endophthalmitis[J]. Bmc Infectious Diseases, 2016, 16(1):496.
[39]	Pavan PR, Oteiza EE, Hughes BA, et al. Exogenous endophthalmitis initially treated without systemic antibiotics[J]. Ophthalmology, 1994, 101(7):1289-1296.
[40]	Listed N. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group[J]. Arch Ophthalmol, 1995, 113(12):1479-1496.
[41]	Barry P, Gardner S, Seal D, et al. Clinical observations associated with proven and unproven cases in the ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery[J]. J Cataract Refract Surg, 2009, 35(9):1523-1531.
[42]	Yan H, Li J. An experimental study on antimicrobial activity of silicone oil in vitro[J]. Ophthalmologica, 2008, 222(4):245-248.
[43]	Yan H, Li J. Experimental study on antiviral activity of silicone oil in vitro[J]. Graefe′s archive for clinical and experimental ophthalmology, 2008, 246(9):1285-1289.
[44]	颜华，陈松，张静楷，等. 白内障术后眼内炎保留人工晶状体的治疗[J]. 中华眼科杂志，2009，45(8):684-687.

病例编号	性别	年龄(岁)	就诊时间(年)	术后眼内炎发生时间(d)	术前视力	眼部情况
病例编号	性别	年龄(岁)	就诊时间(年)	术后眼内炎发生时间(d)	术前视力	角膜水肿	前房	玻璃体混浊
1	男	75	2011	7	光感	＋	前房积脓1 mm	有
2	男	71	2012	2	手动/眼前	＋＋	前房积脓1.5 mm	有
3	男	63	2013	9	指数/10 cm	＋	前房积脓1.5 mm	有
4	女	73	2016	4	手动/眼前	＋	房水混浊，炎症渗出	有
5	男	63	2016	5	手动/眼前	＋	房水混浊，炎症渗出	有
6	男	68	2017	4	手动/眼前	＋	房水混浊，炎症渗出	有
7	男	71	2017	2	指数/10 cm	＋	房水混浊	有
8	男	67	2017	1	指数/30 cm	＋	房水混浊	有
9	男	67	2017	1	手动/眼前	＋＋＋	房水混浊	有

病例编号	性别	年龄(岁)	就诊时间(年)	术后眼内炎发生时间(d)	术前视力	眼部情况
病例编号	性别	年龄(岁)	就诊时间(年)	术后眼内炎发生时间(d)	术前视力	角膜水肿	前房	玻璃体混浊
1	男	75	2011	7	光感	＋	前房积脓1 mm	有
2	男	71	2012	2	手动/眼前	＋＋	前房积脓1.5 mm	有
3	男	63	2013	9	指数/10 cm	＋	前房积脓1.5 mm	有
4	女	73	2016	4	手动/眼前	＋	房水混浊，炎症渗出	有
5	男	63	2016	5	手动/眼前	＋	房水混浊，炎症渗出	有
6	男	68	2017	4	手动/眼前	＋	房水混浊，炎症渗出	有
7	男	71	2017	2	指数/10 cm	＋	房水混浊	有
8	男	67	2017	1	指数/30 cm	＋	房水混浊	有
9	男	67	2017	1	手动/眼前	＋＋＋	房水混浊	有

病例编号	治疗情况				术后视力
病例编号	术前曾行前房冲洗	术前行玻璃体腔内注药	手术情况	IOL情况	术后视力
1	有	无	PPV＋硅油填充	取出IOL	—
2	无	无	PPV＋硅油填充	取出IOL	0.01
3	无	无	PPV＋硅油填充	取出IOL	指数/10 cm
4	有	有	PPV＋眼内注药术	保留IOL	0.40
5	有	有	PPV＋眼内注药术	保留IOL	0.15
6	有	有	PPV＋眼内注药术	保留IOL	0.08
7	有	有	PPV＋眼内注药术	保留IOL	0.40
8	有	有	PPV＋眼内注药术	保留IOL	0.20
9	有	有	眼内注药术	保留IOL	手动/30 cm

病例编号	治疗情况				术后视力
病例编号	术前曾行前房冲洗	术前行玻璃体腔内注药	手术情况	IOL情况	术后视力
1	有	无	PPV＋硅油填充	取出IOL	—
2	无	无	PPV＋硅油填充	取出IOL	0.01
3	无	无	PPV＋硅油填充	取出IOL	指数/10 cm
4	有	有	PPV＋眼内注药术	保留IOL	0.40
5	有	有	PPV＋眼内注药术	保留IOL	0.15
6	有	有	PPV＋眼内注药术	保留IOL	0.08
7	有	有	PPV＋眼内注药术	保留IOL	0.40
8	有	有	PPV＋眼内注药术	保留IOL	0.20
9	有	有	眼内注药术	保留IOL	手动/30 cm

Please choose a citation manager

Content to export